Pluri (PLUR) Share-based Compensation Growth (3y) (2013 - 2025)
Pluri (PLUR) Share-based Compensation Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
4.80% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Pluri |
21.85 Mn |
22.34 Mn |
86,000.00 |
149.77% |
| Date | Value |
|---|
| Dec 31, 2025 |
149.77% |
| Sep 30, 2025 |
228.74% |
| Jun 30, 2025 |
-54.18% |
| Mar 31, 2025 |
80.99% |
| Dec 31, 2024 |
54.81% |
| Sep 30, 2024 |
-44.06% |
| Jun 30, 2024 |
-45.17% |
| Mar 31, 2024 |
-71.58% |
| Dec 31, 2023 |
121.24% |
| Sep 30, 2023 |
-6.90% |
| Jun 30, 2023 |
22.72% |
| Mar 31, 2023 |
42.42% |
| Dec 31, 2022 |
-34.08% |
| Sep 30, 2022 |
-64.70% |
| Jun 30, 2022 |
93.81% |
| Mar 31, 2022 |
-25.24% |
| Dec 31, 2021 |
-51.98% |
| Sep 30, 2021 |
33.93% |
| Jun 30, 2021 |
29.45% |
| Mar 31, 2021 |
64.86% |
